Gilenya and Long Term Effects on Relapsing Remitting MS

30 Jun 2015 Uncategorized

The clinical trial, Transform, showed that long term Gilenya treatment can maintain low disease activity in those with Relapse-Remitting MS. The results also showed relapse rates significantly lower than those using interferon- Beta therapies. Make sure and check out the article in Multiple Sclerosis News Today!

 

Search

+